The Journal of Organic Chemistry
Article
= 8.7 Hz, 2H), 6.79 (brd, J = 1.2 Hz, 1H), 6.71 (dd, J = 8.6, 2.4 Hz,
1H), 6.45 (brd, J = 2.3 Hz, 1H), 5.61 (s, 1H), 4.37 (brs, 1H), 3.61 (s,
(100 MHz, DMSO-d6): δ 155.6, 150.3, 137.61, 137.56, 135.2, 131.9,
131.6, 130.9, 129.5, 129.0, 128.7, 127.9, 127.0, 124.8, 121.5, 121.0,
119.1, 117.3, 115.9, 115.2, 112.2, 111.7, 110.3, 103.5, 39.4, 31.2; IR-
ATR: 3539, 3482, 3055, 2938, 1612, 1508, 1466, 1431, 1357, 1165,
1025, 793 cm−1; HRMS (ESI-TOF) m/z: [M − H]+ calcd for
C30H23N2O2, 443.1754; found, 443.1759.
1
3H); 13C{1H} NMR (100 MHz, CDCl3): δ 161.1 (C−F, JC−F
=
4
242.0 Hz), 149.0, 139.9 (C−F, JC−F = 3.0 H), 138.1, 137.5, 131.8,
130.7, 130.1 (C−F, 3JC−F = 8.0 Hz), 128.4, 128.2, 127.9, 126.9, 125.1,
2
121.5, 120.9, 119.1, 118.6, 115.2, 114.6 (C−F, JC−F = 21.0 Hz),
111.60, 111.59, 109.4, 104.4, 39.1, 30.9; 19F NMR (376 MHz,
CDCl3): δ −118.0 to −118.1 (m); IR-ATR: 3420, 3032, 2940, 1602,
1503, 1465, 1358, 1217, 1155, 1093, 1014, 791 cm−1; HRMS (ESI-
TOF) m/z: [M − H]+ calcd for C30H22FN2O, 445.1711; found,
445.1715.
3-((5-Bromo-1H-indol-3-yl)(cyclohexyl)methyl)-1-methyl-2-phe-
nyl-1H-indole (3s). Following the general procedure, the products
were purified by radial chromatography using a gradient of 0−70%
EtOAc in hexanes, furnishing the desired product 3s (204.2 mg, 82%
yield) as a green solid (mp: 196−200 °C) and byproduct 4s (15.8 mg,
13% yield) as a red solid in which the spectral data of 4s were in
3-((4-Fluorophenyl)(1-methyl-2-phenyl-1H-indol-3-yl)methyl)-5-
methoxy-1-methyl-1H-indole (3o). Following the general procedure,
the product was purified by radial chromatography using a gradient of
0−70% EtOAc in hexanes, furnishing the desired product 3o (183.1
agreement with those previously reported in the literature.31 3s: H
1
NMR (400 MHz, CDCl3): δ 7.95 (d, J = 7.8 Hz, 1H,), 7.65−7.39 (m,
4H), 7.39−7.21 (m, 5H), 7.06 (dd, J = 8.5, 1.8 Hz, 1H), 6.97 (s, 1H),
6.76 (s, 1H), 6.55 (d, J = 7.8 Hz, 1H), 3.86 (d, J = 11.2 Hz, 1H), 3.44
(s, 3H), 2.47−2.33 (m, 1H), 1.82−1.72 (m, 1H), 1.72−1.58 (m, 4H),
1.34−1.08 (m, 3H), 0.99−0.74 (m, 2H); 13C{1H} NMR (100 MHz,
CDCl3): δ 138.4, 137.6, 133.8, 131.9, 129.3, 128.6, 126.1, 124.2,
121.8, 121.5, 121.4, 120.7, 119.8, 119.1, 115.9, 112.2, 112.1, 109.7,
42.4, 40.0, 32.8, 32.7, 30.7, 26.8, 26.7, 26.6; IR-ATR: 3368, 2919,
2846, 1457, 1359, 1318, 1209, 1098, 794, 739 cm−1; HRMS (ESI-
TOF) m/z: [M + Na]+ calcd for C30H29BrN2Na, 519.1406; found,
519.1420.
1
mg, 77% yield) as a pink solid (mp: 100−102 °C); H NMR (400
MHz, CDCl3): 7.46−7.37 (m, 3H), 7.37−7.27 (m, 4H), 7.22−7.12
(m, 4H), 6.95 (t, J = 7.6 Hz, 1H), 6.89−6.79 (m, 3H), 6.67 (s, 1H),
6.50 (brd, J = 2.3 Hz, 1H), 5.65 (s, 1H), 3.65 (s, 3H), 3.63 (s, 6H);
1
13C{1H} NMR (100 MHz, CDCl3): δ 161.1 (C−F, JC−F = 241.0
4
Hz), 153.4, 140.1 (C−F, JC−F = 3.0 Hz), 138.1, 137.6, 132.6, 131.9,
130.7, 130.1 (C−F, 3JC−F = 8.0 Hz), 129.1, 128.4, 128.2, 127.9, 126.9,
2
121.5, 121.1, 119.1, 117.1, 115.5, 114.6 (C−F, JC−F = 21.0 Hz),
111.5, 109.8, 109.4, 101.7, 55.8, 38.9, 32.9, 31.0; 19F NMR (376 MHz,
CDCl3): δ −118.2 to −118.3 (m); IR-ATR: 3053, 2938, 1602, 1503,
1466, 1418, 1359, 1216, 1155, 1015, 817 cm−1; HRMS (ESI-TOF)
m/z: [M − H]+ calcd for C32H26FN2O, 473.2024; found, 473.2031.
3-((5-Bromo-1H-indol-3-yl)(4-nitrophenyl)methyl)-1-methyl-2-
phenyl-1H-indole (3p). Following the general procedure, the
products were purified by radial chromatography using a gradient of
0−70% EtOAc in hexanes, furnishing the desired product 3p (193.8
mg, 72% yield) as an orange solid (mp: 110−112 °C) and byproduct
4p (26.3 mg, 20% yield) as an orange solid in which the spectral data
of 4p were in agreement with those previously reported in the
3-(1-(5-Bromo-1H-indol-3-yl)-2-ethylbutyl)-1-methyl-2-phenyl-
1H-indole (3t). Following the general procedure, the products were
purified by radial chromatography using a gradient of 0−70% EtOAc
in hexanes, furnishing the desired product 3t (203.9 mg, 84% yield) as
a brown solid (mp: 230−232 °C) and byproduct 4t (18.6 mg, 10%
1
yield) as a brown oil (mp: 230−232 °C). 3t: H NMR (400 MHz,
CDCl3): δ 7.98 (d, J = 7.9 Hz, 1H), 7.80 (brs, 1H), 7.59−7.48 (m,
3H), 7.32 (d, J = 7.9 Hz, 1H), 7.29−7.07 (m, 7H), 7.07−6.98 (m,
1H), 4.09 (d, J = 11.5 Hz, 1H), 3.49 (s, 3H), 2.63−2.49 (m, 1H),
1.55−1.46 (m, 1H), 1.46−1.35 (m, 1H), 1.33−1.23 (m, 2H), 0.76−
0.65 (m, 6H); 13C{1H} NMR (100 MHz, CDCl3): δ 138.2, 137.5,
134.0, 132.0, 130.6, 129.5, 128.5, 126.4, 124.3, 122.2, 121.8, 121.3,
120.8, 120.6, 119.0, 116.2, 112.2, 109.6, 44.2, 36.4, 30.7, 22.8, 22.4,
10.18, 10.15; IR-ATR: 3364, 3048, 2960, 2932, 2871, 1607, 1457,
1366, 1101, 1056, 794 cm−1; HRMS (ESI-TOF) m/z: [M + Na]+
calcd for C29H29BrN2Na, 507.1406; found, 507.1410.
literature.30 3p: H NMR (400 MHz, DMSO-d6): δ 11.16 (s, 1H),
1
8.12 (d, J = 8.4 Hz, 2H), 7.58−7.45 (m, 4H), 7.44−7.30 (m, 5H),
7.20 (d, J = 8.4 Hz, 1H), 7.17−7.11 (m, 2H), 7.00 (brd, J = 1.8 Hz,
1H), 6.93−6.86 (m, 2H), 5.72 (s, 1H), 3.61 (s, 3H); 13C{1H} NMR
(100 MHz, DMSO-d6): δ 152.4, 146.3, 138.6, 137.6, 135.6, 131.4,
130.8, 129.9, 129.2, 129.1, 128.7, 126.4, 126.3, 124.2, 123.8, 121.9,
121.0, 120.3, 119.7, 116.3, 114.2, 113.4, 111.6, 110.7, 39.7, 31.3; IR-
ATR: 3404, 3056, 2923, 1594, 1513, 1463, 1341, 1096, 1014, 740
cm−1; HRMS (ESI-TOF) m/z: [M − H]+ calcd for C30H21BrN3O2,
534.0812; found, 534.0810.
3,3′-(2-Ethylbutane-1,1-diyl)bis(5-bromo-1H-indole) (4t). 1H
NMR (400 MHz, CDCl3): δ 7.98 (s, 2H), 7.72 (brd, J = 1.5 Hz,
2H), 7.24−7.15 (m, 4H), 7.09 (brd, J = 2.3 Hz, 2H), 4.39 (d, J = 8.6
Hz, 1H), 2.26−2.16 (m, 1H), 1.56−1.46 (m, 2H), 1.41−1.28 (m,
2H), 0.88 (t, J = 7.4 Hz, 6H); 13C{1H} NMR (100 MHz, CDCl3): δ
134.9, 129.2, 124.6, 123.0, 122.0, 118.7, 112.6, 112.4, 44.5, 36.4, 23.3,
11.2; IR-ATR: 3421, 1615, 1457, 1417, 1226, 1101, 1096, 793 cm−1;
HRMS* (ESI-TOF) m/z: [M − H]− calcd for C22H21Br2N2,
471.0077; found, 471.0077.
4-((5-Bromo-1H-indol-3-yl)(1-methyl-2-phenyl-1H-indol-3-yl)-
methyl)phenol (3q). Following the general procedure, the products
were purified by radial chromatography using a gradient of 0−70%
EtOAc in hexanes, furnishing the desired product 3q (181.0 mg, 71%
yield) as a red solid (mp: 122−124 °C) and byproduct 4q (32.2 mg,
26% yield) as a red solid in which the spectral data of 4q were in
3-(2-Ethyl-1-(1-methyl-2-phenyl-1H-indol-3-yl)butyl)-1H-indol-
5-ol (3u). Following the general procedure, the product was purified
by radial chromatography using a gradient of 0−70% EtOAc in
hexanes, furnishing the desired product 3u (168.9 mg, 80% yield) as a
agreement with those previously reported in the literature.28 3q: H
1
NMR (400 MHz, CDCl3): δ 7.92 (s, 1H), 7.49−7.38 (m, 3H), 7.36−
7.28 (m, 4H), 7.22−7.14 (m, 4H), 7.12−7.06 (m, 2H), 6.92 (td, J =
7.5, 0.7 Hz, 1H), 6.84 (brd, J = 1.4 Hz, 1H), 6.70−6.64 (m, 2H), 5.60
(s, 1H), 4.55 (s, 1H), 3.62 (s, 3H); 13C{1H} NMR (100 MHz,
CDCl3): δ 153.7, 138.2, 137.6, 136.2, 135.1, 131.8, 130.7, 129.7,
129.1, 128.4, 128.3, 126.9, 124.8, 124.6, 122.3, 121.4, 121.0, 119.7,
119.0, 115.1, 114.9, 112.40, 112.37, 109.4, 38.7, 30.9; IR-ATR: 3403,
3053, 2920, 1608, 1508, 1457, 1359, 1217, 1168, 1092, 741 cm−1;
HRMS (ESI-TOF) m/z: [M − H]+ calcd for C30H22BrN2O,
505.0910; found, 505.0918.
1
gray solid (mp: 108−110 °C); H NMR (400 MHz, CDCl3): δ 8.0
(d, J = 7.9 Hz, 1H), 7.69 (s, 1H), 7.54−7.35 (m, 4H), 7.31 (d, J = 8.2
Hz, 1H), 7.28−7.20 (m, 2H), 7.20−7.11 (m, 2H), 7.10−7.04 (m,
1H), 6.66 (d, J = 8.2 Hz, 1H), 6.35 (brd, J = 2.1 Hz, 1H), 4.29 (brs,
1H), 4.14 (d, J = 11.4 Hz, 1H), 3.50 (s, 3H), 2.57−2.46 (m, 1H),
1.58−1.49 (m, 1H), 1.47−1.37 (m, 1H), 1.35−1.24 (m, 2H), 0.75−
0.64 (m, 6H); 13C{1H} NMR (100 MHz, CDCl3): δ 148.8, 138.0,
137.6, 132.5, 130.9, 129.4, 128.5, 128.2, 128.1, 126.7, 122.3, 121.2,
120.8, 120.4, 118.9, 116.3, 111.3, 111.1, 109.5, 103.9, 44.4, 36.4, 30.8,
22.8, 22.4, 10.3, 10.1; IR-ATR: 3393, 2958, 2935, 2870, 1542, 1457,
1359, 1208, 1175, 1019, 743 cm−1; HRMS (ESI-TOF) m/z: [M +
Na]+ calcd for C29H30N2NaO, 445.2250; found, 445.2253.
3-((4-Hydroxyphenyl)(1-methyl-2-phenyl-1H-indol-3-yl)methyl)-
1H-indol-5-ol (3r). Following the general procedure, the product was
purified by radial chromatography using a gradient of 0−70% EtOAc
in hexanes, furnishing the desired product 3r (187.1 mg, 84% yield) as
1
a red solid (mp: 214−216 °C); H NMR (400 MHz, DMSO-d6): δ
3-((1H-Indol-3-yl)(phenyl)methyl)-1,2-dimethyl-1H-indole (3v).
Following the general procedure, the products were purified by radial
chromatography using a gradient of 0−70% EtOAc in hexanes,
furnishing the desired product 3v (98.5 mg, 56% yield) as a pink solid
and byproduct 4a (14.6 mg, 18% yield) as a red solid. The spectral
10.44 (s, 1H), 9.12 (s, 1H), 8.41 (s, 1H), 7.56−7.36 (m, 6H), 7.22 (d,
J = 7.6 Hz, 1H), 7.15−7.05 (m, 2H), 6.92 (d, J = 8.5 Hz, 2H), 6.83 (t,
J = 7.6 Hz, 1H), 6.64−6.56 (m, 3H), 6.52 (dd, J = 8.5, 2.3 Hz, 1H),
6.25 (brd, J = 2.1 Hz, 1H), 5.36 (s, 1H), 3.60 (s, 3H); 13C{1H} NMR
2321
J. Org. Chem. 2021, 86, 2312−2327